Blood Cancer UK Project Grants — 2027–2028

Support discovery and preclinical translational research on blood cancers and precursor conditions, across prevention, early detection/outcome prediction and treatment. Projects can request up to GBP 350,000 for 12–36 months, with starts no earlier than August 2027. Small clinical studies may qualify, but clinical-trial applications, bridging funding, shortfall supplements and biobank/infrastructure funding are excluded. The round also includes a RUNX1-focused co-funded opportunity under the same main eligibility and deadline.

Scientists, clinicians or healthcare professionals with postdoctoral-equivalent experience at UK universities, hospitals or recognised research institutions. Permanent/long-term host-paid contracts are usual; senior postdocs and early-career leads can request salary support with a tenured host co-applicant or a Head of Department guarantee of space, facilities and support. Commercial employees are excluded. Existing Blood Cancer UK project-grant holders need less than twelve months remaining at the July 2027 award date. Required institutional signatories must approve before 21 January 2027, 3 pm UK time.